original articlesgastrointestinal tumorsMasitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial
gastrointestinal tumors
Under a Creative Commons license
open access
Key words
GIST
imatinib-resistant GIST
phase II study
tyrosine kinase inhibitor
Cited by (0)
Copyright © 2014 THE AUTHORS. Published by Elsevier Ltd.